Tu2038 All Oral Fixed-dose Combination...

Gastroenterology 2014 / 05 Vol. 146; Iss. 5

Tu2038 All Oral Fixed-dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Naive Genotype 1 HCV-Infected Patients: The Phase 3 ION-1 Study

Jacobson, Ira M., Marcellin, Patrick, Mangia, Alessandra, Kwo, Paul Y., Foster, Graham, Buti, Maria, Brau, Norbert, Muir, Andrew J., Yang, Jenny C., Mo, Hongmei, Ding, Xiao, Pang, Phil, Symonds, Willi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
146
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(14)63284-4
Date:
May, 2014
File:
PDF, 46 KB
english, 2014
Conversion to is in progress
Conversion to is failed